• Zocdoc is private, so it has no directly investable public ticker; its AI and payer partnerships are worth monitoring for evidence of adoption and revenue growth.
• Alphabet (GOOGL/GOOG) has partnered with Zocdoc through Gemini, but no deal economics or usage figures were disclosed, so the partnership alone does not support a buy recommendation.
• Track healthcare-access and scheduling companies for measurable gains in completed bookings and payer integrations; the insights provide no public-stock price targets or near-term trade signals.

Zocdoc (Private company; no ticker mentioned)

• Zocdoc is expanding from a consumer doctor-booking marketplace into healthcare access infrastructure that other platforms, payers, and AI agents can use.
• CEO Oliver Kharraz said Zocdoc’s provider data is more than 99% accurate and connects to 175+ EHR systems. He described the integrations and the varied ways practices manage schedules as difficult problems that took years to solve.
• The company says patients can typically get an appointment through Zocdoc within three days or less, compared with a nationwide average primary-care wait of 31 days. Kharraz said the national average was 17 days when Zocdoc started.
• Zocdoc reports a 75–80% rebooking rate with the same provider within a specialty. It also said 97% of providers signed in the prior 12 months came to the company inbound, which it attributes to word of mouth.
• Its provider model charges for a “discovery booking”—when Zocdoc connects a patient searching generally with a provider—but not when it simply facilitates booking with a doctor the patient already chose. Payer arrangements are monetized differently, depending on the relationship.
• The company says it screens providers and removes those who do not meet its standards. Its network spans 250 specialties, including oncology.

Takeaways

• The investment case described is a shift from a consumer marketplace toward an access and distribution layer for healthcare. If more AI platforms and payers route patients through Zocdoc, its infrastructure could become valuable beyond its own website and app.
• The discussion offers encouraging operating indicators, but no revenue, profitability, valuation, or funding details. Zocdoc is not presented as a publicly traded investment, so the transcript does not support a direct public-stock recommendation.
• Execution remains complex: integrations must account for inconsistent EHR use and practice workflows, and healthcare scheduling information can be difficult to keep current. The CEO also noted that nationwide primary-care wait times have worsened since the company began.

Alphabet (GOOGL, GOOG) / Gemini

• Zocdoc announced a partnership with Gemini to help users find and book healthcare appointments. Kharraz said AI can make patient engagement more personalized and more likely to lead to action, while Zocdoc supplies the booking capability.
• Zocdoc says it intends to make provider availability available across multiple AI and consumer platforms, rather than requiring bookings to happen on Zocdoc’s own properties.

Takeaways

• The partnership illustrates a possible role for AI assistants as a new way for consumers to discover and access services, with established platforms supplying the underlying transaction infrastructure.
• For Alphabet, the transcript describes a product partnership, but gives no deal terms, usage figures, or financial contribution. It is not enough on its own to assess the partnership’s impact on Alphabet’s investment outlook.

Healthcare access infrastructure and AI

• The discussion highlights an opportunity to reduce friction in healthcare by connecting provider availability, insurance information, and booking across different platforms.
• Payer partnerships may create a route to reach members where they already search for in-network care. Zocdoc cited Blue Shield of California as an example of a member directory that enables direct appointment booking.
• Kharraz said better scheduling can help use provider capacity that would otherwise be lost to cancellations and no-shows. He compared doctors’ roughly 70% utilization with airlines’ reported load factors above 90%, while noting that Zocdoc aims to fill last-minute openings.
• The company’s stated approach is to let patients—or their AI agents—choose among available providers rather than having one platform control the “front door” to care.

Takeaways

• The transcript points to potential investment themes in healthcare technology, AI-enabled service discovery, provider scheduling, and payer-provider connectivity. The opportunity depends on whether these tools can translate better discovery into completed appointments and sustainable business models.
• Track whether AI partnerships and payer integrations lead to measurable adoption, broader provider participation, and financial results. The episode provides no forecasts, price targets, or quantified revenue impact.
• Healthcare access is not solved nationwide: the CEO said the average primary-care wait has risen to 31 days, even though Zocdoc reports much faster access for patients using its platform.